Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trial.
about
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trial.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Immunogenicity and safety of a ...... randomized, controlled trial.
@ast
Immunogenicity and safety of a ...... randomized, controlled trial.
@en
type
label
Immunogenicity and safety of a ...... randomized, controlled trial.
@ast
Immunogenicity and safety of a ...... randomized, controlled trial.
@en
prefLabel
Immunogenicity and safety of a ...... randomized, controlled trial.
@ast
Immunogenicity and safety of a ...... randomized, controlled trial.
@en
P2093
P1433
P1476
Immunogenicity and safety of a ...... , randomized, controlled trial
@en
P2093
Anne Schuind
Anuradha Madan
Azhar Toma
Damien Friel
David Seiden
Jyoti Soni
Murdo Ferguson
Paul Rheault
P304
P356
10.1016/J.VACCINE.2017.02.057
P407
P577
2017-03-13T00:00:00Z